|Bid||86.80 x 800|
|Ask||88.28 x 800|
|Day's Range||85.58 - 86.69|
|52 Week Range||74.09 - 94.26|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||27.09|
|Forward Dividend & Yield||3.33 (3.77%)|
|Ex-Dividend Date||Mar 08, 2022|
|1y Target Est||N/A|
Novartis ( VTX:NOVN ) Full Year 2022 Results Key Financial Results Revenue: US$51.8b (down 2.0% from FY 2021). Net...
Novartis (NVS) reports mixed fourth-quarter results, with key brands maintaining momentum but Cosentyx sales declining and generic competition remaining a drag.
NVS earnings call for the period ending December 31, 2022.